Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention

Giuseppe Patti(Università Campus Bio-Medico), Vincenzo Pasceri(Ospedale San Filippo Neri), Giuseppe Colonna(Ospedale Vito Fazzi), Marco Miglionico(Università Campus Bio-Medico), Dionigi Fischetti(Ospedale Vito Fazzi), Gennaro Sardella(Sapienza University of Rome), Antonio Montinaro(Ospedale Vito Fazzi), Germano Di Sciascio(Università Campus Bio-Medico)

Journal of the American College of Cardiology

March 1, 2007

10.1016/j.jacc.2007.02.025

Cited by 480

Abstract

Related Papers

Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction

Elliott M. Antman, Jean‐Pierre Bassand, Werner Klein et al.|Journal of the American College of Cardiology|2000|4.8k

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

J. Tuomilehto, Gabriele Vidgrén, L. Toivanen et al.|The Lancet|1994|1.7k

Effect of Statin Therapy on C-Reactive Protein Levels

Michelle A. Albert, Ellie Danielson, Nader Rifai et al.|JAMA|2001|1.7k

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes

James A. de Lemos, Michael A. Blazing, Stephen D. Wiviott et al.|JAMA|2004|1.3k

Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs

Vincenzo Pasceri, J.Y. Chang, James T. Willerson et al.|Circulation|2001|831